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Escherichia coli O26 has been identified as the most common non-O157 Shiga toxin-producing E. coli (STEC) serogroup to cause
human illnesses in the United States and has been implicated in outbreaks around the world. E. coli has high genomic plasticity,
which facilitates the loss or acquisition of virulence genes. Attaching and effacing E. coli (AEEC) O26 strains have frequently
been isolated from bovine feces, and there is a need to better characterize the relatedness of these strains to defined molecular
pathotypes and to describe the extent of their genetic diversity. High-throughput real-time PCR was used to screen 178 E. coli
O26 isolates from a single U.S. cattle feedlot, collected from May to July 2011, for the presence or absence of 25 O26 serogroup-
specific and virulence-associated markers. The selected markers were capable of distinguishing these strains into molecularly
defined groups (yielding 18 unique marker combinations). Analysis of the clustered regularly interspaced short palindromic
repeat 1 (CRISPR1) and CRISPR2a loci further discriminated isolates into 24 CRISPR types. The combination of molecular
markers and CRISPR typing provided 20.8% diversity. The recent CRISPR PCR target SP_O26-E, which was previously identi-
fied only in stx2-positive O26:H11 human clinical strains, was identified in 96.4% (161/167 [95% confidence interval, 99.2 to
93.6%]) of the stx-negative AEEC O26:H11 bovine fecal strains. This supports that these stx-negative strains may have previously
contained a prophage carrying stx or could acquire this prophage, thus possibly giving them the potential to become pathogenic
to humans. These results show that investigation of specific genetic markers may further elucidate our understanding of the ge-
netic diversity of AEEC O26 strains in bovine feces.
Escherichia coli O26 has been identified as the most commonnon-O157 Shiga toxin-producing E. coli (STEC) serogroup to
cause human illnesses resulting in hemorrhagic colitis and hemo-
lytic-uremic syndrome (HUS) in the United States and in Europe
(1–3). In an effort to ensure a safer food supply, in 2012, the U.S.
Department of Agriculture Food Safety and Inspection Service
(FSIS) expanded the list of serogroups designated adulterants in
raw nonintact beef and products that will become nonintact beef
to include non-O157 STEC serogroups O26, O45, O103, O111,
O121, and O145 (4).
Cattle have been implicated as a reservoir for E. coli O26, and
cattle likely serve as an important source of contamination of raw
agriculture products that come into contact with contaminated
manure, including beef, dairy, and produce (5, 6). Additionally, E.
coli O26 is a highly diverse serogroup, and strains can vary from
highly pathogenic to avirulent, nonpathogenic variants (7–10).
Furthermore, this distribution of molecularly defined E. coli O26
pathogroups within bovine feces has not been fully described.
In E. coli, most virulence factors are located on potentially mo-
bile elements (phages, plasmids, and pathogenicity islands),
which can rapidly be exchanged, acquired, or lost, such as Shiga
toxin phages (7–9, 11). This genetic exchange of virulence factors
may have contributed to the genetic shift and clonal development
observed within the E. coli O26 serogroup (12). Prior to the emer-
gence of the new Stx2a-producing clone in the mid-1990s, the
majority of E. coli O26:H11 isolates recovered from humans were
primarily only stx1 positive or, not as common, positive for stx1 in
combination with stx2 but not stx2 alone (13). Based on strains
harboring these Shiga toxin combinations, pathogroups were dis-
tinguished by their pathogenicity, severity of disease, and select
virulence factors. Enterohemorrhagic E. coli (EHEC) O26:H11
isolates were defined as being positive for stx and eae (beta variant)
and also possibly possessing a specific allelic type of arcA (arcA
allele 2) (14). This definition was further modified to include pos-
sible associations with other virulence factors such as espK and
espN (7). Enteropathogenic E. coli (EPEC) O26 isolates were de-
fined as being eae positive, stx negative, and espK negative, and
EPEC O26 may be associated with a distinct allele of arcA (arcA
allele 1) (7, 8).
The dissemination of a new highly virulent EHEC O26:H11
clone harboring only stx2a across Europe (5, 12, 13, 15–22) and,
more recently, other parts of the world, including the United
States (1, 23), further expands the classification scheme and con-
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tinues to challenge the understanding of this diverse serotype.
Bielaszewska et al. (12) used multilocus sequence typing to show
that this new clone belongs primarily to sequence type 29 (ST29).
Further investigation into this new highly pathogenic EHEC O26:
H11 clone identified a second subpopulation of EHEC isolates
carrying the stx2a or stx2d variant and lacking espK and arcA allele
2 but being positive for eae-beta and the SP_O26-E clustered reg-
ularly interspaced short palindromic repeat (CRISPR) PCR
marker (19).
Previous studies have identified EHEC-like O26:H11 strains
that express all of the genetic features of EHEC O26:H11 except
for the presence of Shiga toxin-encoding genes (stx1 and/or stx2)
(7, 24, 25). These strains might have lost their stx phage during
culture, or alternatively, they might constitute a reservoir for
EHEC O26 upon the subsequent acquisition of an stx phage. Fur-
thermore, some Shiga toxin-negative strains have been identified
to cause severe human illness (26–28). Although Shiga toxin-pos-
itive O26:H11 has been extensively studied, there is a lack of avail-
able literature on non-Shiga toxin variants. Based on molecular
characteristics that have previously been described (8, 24, 29–31),
we attempt to assess the relatedness of Shiga toxin-negative and
eae-positive E. coli O26 strains from cattle to highly pathogenic
O26 clones isolated in humans.
MATERIALS AND METHODS
Escherichia coli strains. The strains investigated in this study (n  178)
were isolated from the feces of U.S. feedlot cattle. Strains originated from
fecal samples collected between May and July 2011 from a study involving
17,148 cattle housed in 40 pens at a commercial feedlot in the Midwest
(32). There is no known association of these strains with any human
illness. Escherichia coli DNA was extracted by using an InstaGene matrix
(Bio-Rad Laboratories, Marnes-La-Coquette, France) according to the
manufacturer’s guidelines. Escherichia coli strains, belonging to a collec-
tion at the French Agency for Food, Environmental and Occupational
Health and Safety (Anses), that were used as PCR controls in this study
included E. coli 07QMA 144.1 (avirulent O26:H11), ED21 (EHEC O26:
H11; stx1 positive [stx1
]), EH196 (EHEC O26:H11; stx2
), MB01
(EHEC-like O26:H11), EC293 (O26:H32), ED142 (O111:H8), and
E2348/69 (EPEC O127:H6).
Molecular markers. PCR amplification was used to investigate 25 mo-
lecular markers for the characterization of the E. coli O26 strains in this
study (see Table S1 in the supplemental material for oligonucleotides).
Genetic markers included genes coding for the O26 antigen flippase
(wzxO26); Shiga toxins 1 and 2 (stx1 and stx2); adhesion factors (eae, eae-
beta, and iha); the flagellar antigens H11 (fliCH11), H32 (fliCH32), and H8
(fliCH8); effectors translocated by the type III secretion system (espK,
espV, and espN); the EHEC hemolysin (ehxA); the long polar fimbriae
[lpfA(O26)]; the bundle-forming pili (bfpA); the iron-repressible protein
Irp2 (irp2); bacterial tellurite resistance (terE); urease (ureD); open read-
ing frames of O island 57 (OI-57), Z2098 and Z2099; the CRISPR-associ-
ated markers SP_O26-C, SP_O26-D, and SP_O26-E; aerobic respiratory
control protein A allele 2 (arcA allele 2); and the reference genetic marker
for E. coli (wecA).
High-throughput real-time PCR. DNA amplifications were obtained
through a combination of multiple high-throughput real-time PCR plat-
forms. The PCR setup for the LightCycler 1536 system (Roche, Meylan,
France) with a Bravo automated liquid dispenser (Agilent Technologies,
Massy, France) was previously described (9, 29). Setup for the BioMark
real-time PCR system (Fluidigm, San Francisco, CA) with the 192.24 Dy-
namic array (Fluidigm) was performed according to the manufacturer’s
recommendations, using 6-carboxyfluorescein (FAM)- and 6-carboxy-
2=,4,4=,5=,7,7=-hexachlorofluorescein succinimidyl ester (HEX)-labeled
TaqMan probes and TaqMan gene expression PCR master mix (Applied
Biosystems, Courtaboeuf, France). The thermal profile for the BioMark
PCR was described previously (7). A LightCycler 480 (Roche, Meylan,
France) or LightCycler Nano (Roche, Meylan, France) system was also
used to perform additional real-time PCR amplifications.
CRISPR typing. The CRISPR1 and -2a loci were amplified by PCR as
previously described (33). Double-stranded DNA sequencing of the
CRISPR1 and CRISPR2a loci was performed by Eurofins MWG Operon
(Courtaboeuf, France). Sequences were assembled and aligned by using
the BioEdit biological sequence alignment editor (v7.2.5; BioEdit, Carls-
bad, CA [http://www.mbio.ncsu.edu/Bioedit/bioedit.html]).
Analysis of CRISPR sequences was performed by using a Python Script
(2.7.6) developed in-house. This script uses a method developed by Yin et
al. (34) to assign allele numbers for each strain. Briefly, each unique spacer
and repeat are recorded in separate databases associated with a number
and a letter, respectively. Each unique spacer combination within a
CRISPR locus defines a CRISPR allele, the listing of which is also con-
tained in a database. Each unique CRISPR1 and -2a allele combination
was manually assigned an arbitrary CRISPR type (CT).
Descriptive analysis. The EHEC pathogroup is defined here as strains
harboring stx1 and/or stx2, eae, espK, and arcA allele 2, as described previ-
ously by Bugarel et al. (7), or as stx2-positive strains that tested negative for
espK and arcA allele 2 but positive for eae and the SP_O26-E CRISPR PCR
marker (35). EHEC-like strains are devoid of Shiga toxin genes but possess
the above-mentioned virulence genes (eae, espK, and arcA allele 2) found
in EHEC strains (7). Furthermore, EHEC-like strains derived from the
newly described stx2 clone would be expected to test negative for espK and
arcA allele 2 but positive for eae and the SP_O26-E CRISPR PCR marker
(35). EPEC isolates are defined here by the absence of Shiga toxin-encod-
ing genes, espK, arcA allele 2, and SP_O26-E but the presence of the in-
timin gene (eae). The presence of an E. coli adherence factor plasmid
carrying bfpA may or may not also be present in EPEC isolates and has
been used to classify EPEC isolates as typical and atypical, with the latter
not being associated with HUS or the bundle-forming pilus gene bfpA
(7–9, 30, 36). Avirulent, nonpathogenic E. coli O26 isolates are distin-
guished based on the absence of Shiga toxin genes, eae, and all other
virulence-associated markers (espK, espV, SP_O26-E, and arcA allele 2).
Relative frequencies were calculated for molecular markers among
specified groups, and 95% confidence intervals (CIs) are reported (37).
Combinations of various molecular markers were used to group strains
into discrete marker types (MTs). Further combination of the MTs with
the CTs allowed the definition of diversity types (DTs). Simpson’s index
of diversity (1  D) was used to determine the genetic diversity of MTs
and the discrimination power of the combined typing methods (DTs): the
greater the value reported, the greater the sample diversity (38, 39). A
hierarchical clustering dendrogram was constructed by using the molec-
ular markers for each DT. The presence or absence of each marker was
binomially coded as 1 or 0, respectively, and data were clustered by using
Ward classification and Euclidean squared distances (STATGRAPHICS
Centurion XV v15.2).
RESULTS
Molecular markers. The 178 E. coli strains of bovine fecal origin
investigated were confirmed to be E. coli and to belong to the O26
serogroup by using the wecA and wzxO26 genetic markers, respec-
tively. The flagellar antigen was identified as H11 (fliCH11) for all
strains, which consequently tested negative for fliCH8 and fliCH32.
All strains also tested positive for both eae and eae-beta. The dis-
tributions and patterns of the 18 remaining genes are presented in
Table 1. A hierarchical clustering dendrogram of the molecular
markers is presented in Fig. 1. The combination of genetic mark-
ers present within a strain provided discrimination through the
construction of unique MTs (Table 1). All strains tested positive
for irp2, which encodes the iron-repressible protein. With the ex-
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ception of one strain, all strains contained the long polar fimbria
gene lpfA(O26).
Discrimination of strains into their respective groups was per-
formed based on the association of the virulence markers investi-
gated. In this study, all strains tested negative for stx2, and five
strains were perfectly associated with the genetic markers stx1, eae,
espK, and arcA allele 2. The presence of these markers is in agree-
ment with data for human strains classified in the EHEC patho-
group. Additionally, the presence of espN, which encodes an ef-
fector protein, translocated by the type III secretion system, was
detected only in the stx1
 espK strains. One strain, although it
contained stx1, lacked many other virulence-associated genes ob-
served in the other Shiga toxin-positive strains, including espK
and arcA allele 2. However, given that this strain contained in-
timin (eae) and SP_O26-E, with the latter marker not being ob-
served in the previous five strains, it may have a different patho-
genicity potential than the above-mentioned strains. Although
negative for stx2, this strain (MT1) displayed the characteristic
pattern of the new virulent stx2a clone (12, 15, 35).
In this study, five strains that displayed the characteristic pro-
file of EHEC-like strains were identified, possessing the virulence-
associated factors eae, espK, and arcA allele 2 and lacking stx. A
further 161 E. coli O26:H11 strains were negative for espK and arcA
allele 2 but were positive for eae and the SP_O26-E CRISPR
marker. Given the profile of these strains, they might also be clas-
sified as EHEC-like strains, which may have derived from the new
stx2 clone. These strains were further divided into 11 MTs.
Given the absence of bfpA; which is located on the E. coli ad-
herence factor plasmid; Shiga toxins; espK; arcA allele 2; and the
CRISPR marker SP_O26-E, six O26:H11 strains represent three
MTs (MTs 5 to 7) (Table 1) in this study and are most similar to
human clinical isolates previously categorized as being atypical
EPEC. No strains that lacked all the virulence-associated markers
investigated were identified in this bank of strains.
The EHEC hemolysin gene ehxA was observed in five strains
(MTs 2 and 3) and seven strains (MTs 4, 15, and 18) that displayed
EHEC and EHEC-like profiles, respectively. An effector protein
translocated by the type III secretion system, encoded by espV, was
present in 33.5% (95% CI, 26.81 to 40.99%) of strains; positive
strains belonged to MTs 2, 3, 12 to 16, and 18. The gene encoding
urease production, ureD, was present in all but one of the strains
with an EHEC profile (MT1) and in six strains exhibiting the
EHEC-like profile (MTs 4 and 18). The gene encoding the adher-
ence-conferring protein, iha, was present in MTs 2, 3, 4, 17, and
18, encompassing 28 strains.
According to Delannoy et al. (29), the presence of the open
reading frames Z2098 and Z2099 carried on genomic OI-57 pro-
vided discrimination of EHEC and EHEC-like strains from strains
belonging to other E. coli O26 pathogroups. Our strains that dis-
play profiles similar to those of these pathogroups are in accor-
dance with these findings for only those strains that are positive for
arcA allele 2, with the exception of one arcA allele 2-negative strain
(MT18). This particular strain also carries many other virulence-
associated markers (espV, ureD, iha, and ehxA), similar to those
that have been found in the EHEC pathogroup (29). Although
phenotypic expression was not investigated in this study, previ-
ously reported findings support that EHEC and atypical EPEC
O26 expression of tellurite resistance correlates identically with
the presence of ter genes (40–42). A large proportion of the strains
(117/178; 65.7% [95% CI, 58.7 to 72.7%]), with the exception of
61 strains, contained terE.
The CRISPR-associated markers SP_O26-C and SP_O26-D
were previously developed and identified, which, when present
alone or in combination, allowed 100% sensitivity and 97.5%





stx1 eae-beta espK espV ureD Z2098 Z2099 iha ehxA espN terE irp2 SP_O26-C SP_O26-D SP_O26-E bfpA lpfA(O26) arcA2
1 1                  
2 3                  
3 2                  
4 5                  
5 1                  
6 4                  
7 1                  
8 7                  
9 9                  
10 70                  
11 2                  
12 2                  
13 39                  
14 12                  
15 1                  
16 1                  
17 17                  
18 1                  
Total (%)c 3.4 100 5.6 34.3 6.2 6.2 6.2 15.7 6.7 2.8 65.7 100 50.6 10.1 91.0 0 99.4 5.6
a The controls in this study belong to a collection at Anses and were used solely as PCR controls. Comparisons to the genotype profiles of these strains were not made. Escherichia
coli control strains (and the corresponding genetic markers) were 07QMA 144.1 (wecA wzxO26 fliCH11), ED21 (stx1 espV Z2098 Z2099), EH196 [stx2 espK SP_O26-C SP_O26-D terE
arcA2 lpfA(O26) ehxA], MB01 (espN eae eae-beta ureD iha irp2), EC293 (fliCH32), ED142 (fliCH8), E2348/69 (bfpA), and 5292A (SP_O26-E) (this study). An exhaustive list of
genetic markers present in each control strain is not included.
b All strains produced a positive result for wecA, wzxO26, eae, and fliCH11, and all strains produced a negative result for stx2, fliCH32, and fliCH8.
c Total percentage of strains with the identified genetic marker.
Characterization of AEEC O26:H11 in U.S. Cattle
June 2015 Volume 81 Number 11 aem.asm.org 3673Applied and Environmental Microbiology





















specificity for the detection of EHEC isolates (33). Of the O26:H11
strains investigated in this study, these CRISPR-associated mark-
ers were absent in 50.0% (3/6 [95% CI, 9.9 to 90.0%]) of the
strains that displayed an EHEC profile. The presence of both the
SP_O26-C and SP_O26-D CRISPR-associated markers was ob-
served in 14.5% (24/166 [95% CI, 9.2 to 19.8%]) of strains with an
EHEC-like profile. Furthermore, one strain (MT18) contained all
of the virulence-associated markers analogous to those of EHEC
strains with the exception of stx, espK, espN, and arcA allele 2.
Additionally, detection of the combination of the CRISPR PCR
markers SP_O26-C and SP_O26-D in 23 of these strains suggests
their close relatedness to EHEC-like strains (33).
The CRISPR-associated marker SP_O26-E was previously
identified only in stx2-positive O26:H11 human clinical isolates
that resulted in HUS (35). Unexpectedly, this CRISPR PCR test
was positive for a large number of strains (162/178; 91.0% [95%
CI, 86.8 to 95.2%]).
CRISPR typing. The O26:H11 strains were investigated for
their CRISPR1 and CRISPR2a loci. The observed CRISPR array
profiles are depicted in Fig. 1. Eleven alleles were identified in the
CRISPR1 loci (6.2% allele diversity; 11 alleles/178 strains) con-
structed from combinations of three direct repeats, 10 spacers,
and one untypeable allele (see Table S2 in the supplemental ma-
terial). Many spacers in the CRISPR1 locus were shared among
strains. Similar to previously reported findings, the CRISPR2a lo-
cus contributes to a greater diversity between alleles than does
CRISPR1 (34, 35, 43). Indicative of this are the six direct repeats,
40 unique spacers, and six untypeable allele sequences that made
up 15 unique CRISPR2a alleles in the O26:H11 bovine strains
(8.4% allele diversity; 15 alleles/178 strains) (see Table S2 in the
supplemental material). The combination of CRISPR1 and
CRISPR2a alleles constituted 24 CRISPR types (CT), which rep-
resent 13.5% allele diversity (24 CTs/178 strains). CT3 was dom-
inant among the strains (79/178), characterizing primarily those
strains that were also positive for the CRISPR PCR marker
SP_O26-E.
All identified spacers, in both CRISPR loci, were 32 bp in
length, with the exception of the presence of two similar trans-
FIG 1 Molecular marker hierarchical clustering dendrogram compared to CRISPR allele profiles. (A) Hierarchical clustering dendrogram of the molecular
markers for each diversity type (DT). (B) Graphic representation of the virulence gene profile and spacer arrangements in CRISPR1 and CRISPR2a of the 178
O26:H11 E. coli strains. Each unique spacer is represented by a unique color combination of the center shape and background. The shape in the center indicates
the spacer length (Œ, 32 bp; , 1,262 bp; A, 1,293 bp). Gaps were introduced to improve the alignment of similar CRISPR arrays. CRISPR1 and -2a allele
numbers (#) are shown in their respective columns to the right of the CRISPR arrays. Each unique molecular gene profile was assigned a marker type (MT)
number. Each unique combination of CRISPR1 and CRISPR2a alleles was assigned a CRISPR type (CT) number. CRISPR alleles denoted with a U indicate that
the CRISPR amplicon was unable to be amplified. The individual combination of an MT and a CT was assigned a DT.
Ison et al.
3674 aem.asm.org June 2015 Volume 81 Number 11Applied and Environmental Microbiology





















posons, of 1,261 and 1,262 bp, in two CRISPR2a spacers that
shared an identity of 1,256 bp (see Table S2 in the supplemental
material). The 1,261-bp transposon is inserted just upstream of
spacer 7 and generates a 1,293-bp spacer. The 1,262-bp trans-
poson does not include a leftover sequence from a known spacer
and generates a 1,262-bp spacer. Interestingly, the 1,261-bp trans-
poson has been previously observed in highly virulent stx2a- and
stx2d-positive O26:H11 human clinical isolates belonging to mul-
tilocus sequence type 29 (ST29) (35).
Within CRISPR1 and CRISPR2a were one and six untypeable
alleles, respectively. These alleles were unable to be amplified by
PCR in their entirety, and therefore, confirmation of the complete
CRISPR allele could not be achieved. Incomplete CRISPR arrays
may have been observed due to the CRISPR alleles being too long
to generate a complete amplicon during PCR, or they may have
lost this CRISPR locus. Conversely, the other CRISPR locus could
be amplified and a CRISPR allele number could be identified,
respectively, for these strains (Fig. 1).
Strain diversity. Within the strains investigated, 18 MTs were
observed (Table 1). Of the MTs identified, strains exhibiting an
EHEC-like profile contributed to 12 MTs. However, 42.2% (70/
166) of strains belonged to MT10, carrying the profile of EHEC-
like strains belonging to the new stx2-positive O26 clone. Further
discrimination among these O26:H11 bovine strains was achieved
through a combination of the MT and CT, allowing 37 diversity
types (DTs), with 20.8% diversity (37 DTs/178 strains), to be rec-
ognized (Fig. 1). Using Simpson’s index of diversity, the genetic
diversities within the MTs and DTs are 0.78 and 0.84, respectively.
DISCUSSION
In E. coli, the O26 serogroup is one of the main causative agents of
HUS worldwide, second only to the O157 serogroup (1–3). EHEC
O26 is considered to have evolved from attaching and effacing E.
coli (AEEC) O26 strains through the acquisition of Shiga toxin
(stx)-encoding genes (28). AEEC strains, which cause typical at-
taching and effacing (A/E) lesions in the intestinal mucosa, are
characterized by the presence of the eae (intimin) gene carried on
LEE (locus of enterocyte effacement). The eae gene is responsible
for the intimate attachment of the bacteria to the cell wall (28, 44).
The aim of this work was to investigate the distribution of E. coli
O26 genotypes within bovine feces and identify the pathogenic
potential of Shiga toxin-negative and eae-positive strains that be-
long to the AEEC pathogroup. Recent findings in Brazil of E. coli
O26 containing the H8 antigen belonging to EHEC and stx-nega-
tive strains led to the inclusion of this antigen in this study (45).
Furthermore, antigen H11 and nonpathogenic antigen H32, com-
monly isolated in food products, were also tested (18, 45–47).
Investigation of the H antigen revealed that all strains were posi-
tive for fliCH11.
The eae gene was detected in all strains investigated in this
study and was further confirmed to be of the eae-beta subtype.
This subtype was previously observed in diarrheagenic clones of
EHEC (44) and EPEC O26:H11 (48). A portion of the strains
investigated here (n  6) display the genetic characteristics to be
classified as an atypical EPEC isolate due to the absence of the
bundle-forming pilus-encoding gene, bfpA, contained in the en-
teroadherent factor (EAF) virulence plasmid (7–9, 36). In con-
trast, typical EPEC isolates that contain bfpA, which allows E. coli
to locally adhere to cultured epithelial cells (36, 49), were absent
from the strains sampled.
In concordance with FSIS guidelines, six of the O26:H11
strains, belonging to MTs 1 to 3, would be classified as adulterants
if present in raw beef products because they were found to harbor
both stx and eae. Furthermore, these strains, along with seven
strains belonging to MTs 4, 15, and 18, displaying the EHEC-like
profile contained EHEC hemolysin, of which two strains displayed
the EHEC-like profile of the new O26 clone. The absence of ehxA
in all other strains suggests the absence of the large EHEC plasmid
carrying this gene (41, 50).
The investigation of molecular markers allowed a high level of
genetic diversity to be observed, with 18 MTs being identified in
these O26:H11 strains (Simpson’s index of diversity  0.78). Fur-
thermore, this observed high level of diversity is interesting given
that the strains investigated here originated from a limited popu-
lation of cattle and were isolated over a short period of time (32).
This high level of genetic diversity contrasts with data for O157:
H7, in which more homogeneity was previously observed with
regard to virulence profiles within this E. coli serotype (34, 51).
The absence of agreement in the level of diversity between O26
and O157 is further supported by a study by Yin et al. (34) in
which only 3 CRISPR sequence types were identified in 57 O157
isolates, compared to the 13 CRISPR sequence types among 48
O26 isolates and the 24 CRISPR types identified in this study.
Whittam et al. (52) also confirmed the high degree of diversity
among O26 strains, demonstrated by 20 electrophoretic types cre-
ated by distinctive multilocus genotypes in 93 O26 isolates.
The commonalities among stx-negative and stx-positive bo-
vine O26:H11 strains are of particular interest. Zhang et al. (13)
determined a commonality among all STEC O26 isolates with the
presence of a high-pathogenicity island (HPI) characterized by the
presence of irp2. Those authors further concluded that this HPI is
genetically stable and a common genome component of the STEC
O26 clonal lineage (13). All O26 strains investigated in this study
were positive for irp2, indicating the presence of this HPI and
suggesting the close relatedness of these strains, including those
that are Shiga toxin negative, to the STEC clonal lineage.
The EHEC pathogroup was previously defined by Bugarel et al.
(7) as harboring stx1 and/or stx2, eae, espK, and arcA allele 2. The
emergence of a new stx2 clone expanded that definition to include
stx2-positive strains that tested negative for espK and arcA allele 2
but positive for eae and the SP_O26-E CRISPR PCR marker (12,
35). Furthermore, EHEC strains can be converted to EHEC-like
strains, and vice versa, by transduction with Shiga toxin phages
(27). Using these definitions, 172 strains could be grouped here as
EHEC and EHEC-like strains. The variability of the virulence-
associated genes espV, iha, terE, lpfA(O26), and ehxA present
among the strains illustrates the diversity of this O26 pathogroup.
One strain with an EHEC-like profile (MT18) in particular con-
tained 13 virulence- and CRISPR-associated markers. Interest-
ingly, only four of these markers [eae-beta, terE, irp2, and
lpfA(O26)] were shared among all strains displaying the EHEC
profile.
The presence of the CRISPR-associated marker SP_O26-E in a
large proportion of the strains (91%) was unexpected. Indeed, this
marker was recently designed to target new highly pathogenic
O26:H11 strains carrying an stx2 gene (including strains carrying
an stx2d gene) and CRISPR2a alleles 67 and 71 (35). Of these
strains, 51.8% (84/162) displayed CRISPR2a allele 67. The similar
CRISPR profiles and virulence genes suggest that these Shiga
toxin-negative strains could have the potential to become highly
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pathogenic to humans through the acquisition of a Shiga toxin
phage. The loss of Shiga toxin genes in E. coli has been observed in
samples from HUS patients that initially excreted stx eae strains
and subsequently produced stx-negative eae strains (26, 27). In
accordance with these observations, one strain screened in this
study, belonging to DT10, tested positive for stx2 in the initial
study where it was isolated (32) and subsequently tested negative
for a Shiga toxin in this study; however, it cannot be determined
when this strain may have lost this Shiga toxin. Therefore, it is
possible that the Shiga toxin-negative strains in this study con-
tained a Shiga toxin at some point that was lost upon initial or
subsequent microbial culturing from bovine feces (27). These
strains could also constitute a reservoir for a new highly patho-
genic O26:H11 clone.
To further investigate the Shiga toxin-negative strains and
their relatedness to human-pathogenic strains, multilocus se-
quence typing was employed on a few strains with various geno-
typic characteristics (35). Two strains belonging to the most dom-
inant genotypic profile (DT12), containing SP_O26-E, as well as a
strain with an EHEC-like profile (DT4; SP_O26-E negative) and a
strain with an espK- and arcA allele 2-negative EHEC profile (DT1;
SP_O26-E positive) were identified as ST29 strains belonging to
ST clonal complex 29 (CC29), while a strain with an espK arcA
allele 2 EHEC profile (DT2; SP_O26-E negative) was determined
to being an ST21 strain belonging to CC29 (data not shown).
Furthermore, one SP_O26-E-negative strain belonging to DT5
(EPEC profile) was determined to belong to ST548 and CC10.
ST29, found in the new clone, is associated with severe human
illness, while ST21 is associated with less severe disease (15, 28,
35). Some strains belonging to ST29 were previously identified in
bovine feces in Scotland and Switzerland (5, 15) although in much
smaller proportions and with the majority of these strains being
stx positive (5). It is acknowledged that only two DT12 strains
were tested; however, given the same molecular and CRISPR pro-
files of all strains in this DT, these results suggest that the Shiga
toxin-negative strains in our study, which are also SP_O26-E pos-
itive, may belong to this clonal complex and have the potential to
become highly pathogenic through the acquisition of a Shiga toxin
gene, supporting the development of new highly pathogenic O26:
H11 clones similar to those observed in Europe (12). Further in-
vestigation into the linkage of these Shiga toxin-negative strains to
the stx2a clone is warranted. In particular, it would be interesting
to conduct a retrospective study on O26 isolates recovered from
bovine feces to substantiate this hypothesis. CC10 was previously
identified in E. coli O26 isolates from cattle and humans in Scot-
land and in E. coli O111 isolates from humans in Germany (2, 5).
Given the genetic relatedness of these serogroups, the strain iden-
tified in this study could potentially cluster closely with O111:H8
given that this CC10 strain was also the only strain negative for the
long polar fimbria gene lpfA(O26) (52, 53). Further investigation
employing whole-genome sequencing will allow this phylogeny to
be determined.
To our knowledge, the distribution of molecularly defined E.
coli O26 pathotypes within U.S. bovine feces has not been previ-
ously described. E. coli O26 is a diverse serogroup, as demon-
strated in this work, with 37 diversity types. Given that we cannot
know the human disease outcome of these bovine fecal strains,
classification into distinct pathogroups is not possible. However,
the array of diversity and pathogenic characteristics observed for
the Shiga toxin-negative strains supports the objective of this
study, through their potential ability to become pathogenic due to
their high degree of similarity with Shiga toxin-positive strains.
These data suggest that high-throughput PCR of select genetic
markers in combination with the use of CRISPR loci as a typing
method can provide a high level of discrimination of E. coli O26:
H11 strains isolated from bovine feces (Simpson’s index of diver-
sity  0.84), thus building upon the development of CRISPR typ-
ing as an efficient and definitive method for establishing cases and
sources of foodborne outbreaks associated with products of bo-
vine origin.
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